Literature DB >> 12034941

Blunt renal trauma: minimally invasive management with microcatheter embolization experience in nine patients.

Hans-Peter Dinkel1, Hansjörg Danuser, Jürgen Triller.   

Abstract

PURPOSE: To evaluate superselective embolization therapy for the management of arterial damage in patients with severe renal trauma.
MATERIALS AND METHODS: Nine consecutive patients with renovascular injuries after blunt trauma underwent superselective embolization. Six patients had pseudoaneurysms or traumatic arteriovenous fistulas. Three patients had frank, uncontained extravasation (two shattered kidneys, one complete pedicle avulsion) and were treated immediately after admission. Two patients were hemodynamically unstable. All patients underwent embolization with 3-F coaxial microcatheters and polyvinyl alcohol particles (n = 2) or 0.018-inch platinum microcoils (n = 7). Procedural and medical success and complications (eg, postembolization syndrome, abscess, permanent serum creatinine elevation, hypertension) were retrospectively assessed from the patients' records. Mean clinical follow-up was 11.9 months (range, 1-50 months).
RESULTS: In all cases bleeding was effectively controlled with superselective embolization in a single session. There was no procedure-related loss of renal tissue in eight cases; in one patient, a lower pole remnant of 20% of viable ipsilateral parenchyma was lost due to the procedure. In one patient, a coil migrated into a lumbar artery without causing clinical consequences. None of the patients developed abscess, hypertension, or procedure-related impairment of renal function.
CONCLUSION: Superselective embolization may be used for effective, minimally invasive control of active renovascular bleeding.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034941     DOI: 10.1148/radiol.2233011216

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  28 in total

1.  [Spontaneous rupture of a lumbar artery. A rare etiology of retroperitoneal hematoma].

Authors:  F Schuster; F Stösslein; F Steinbach
Journal:  Urologe A       Date:  2003-02-07       Impact factor: 0.639

2.  Transcatheter arterial embolization in the trauma patient: a review.

Authors:  Jason R Bauer; Charles E Ray
Journal:  Semin Intervent Radiol       Date:  2004-03       Impact factor: 1.513

3.  Transcatheter ablation of an iatrogenic renal artery pseudoaneurysm with absolute alcohol: a rare case report.

Authors:  Jahangir Beig; Imran Hafeez; Nisar Ahmed Tramboo; Hilal Rather; Irfan Yaqoob
Journal:  Indian Heart J       Date:  2014-12-02

Review 4.  [Renal trauma: is open surgery still up to date?].

Authors:  W Diederichs; S Mutze
Journal:  Urologe A       Date:  2003-02-06       Impact factor: 0.639

5.  Renal artery pseudoaneurysm: an unexpected mode of closure during coil embolisation.

Authors:  Srinivasa K Hemanna Setty; Rajiv Ananthakrishna; Manjunath C Nanjappa
Journal:  Heart Asia       Date:  2013-10-04

6.  [Contrast-enhanced sonography for blunt force abdominal trauma].

Authors:  F Schwarz; W H Sommer; M Reiser; D-A Clevert
Journal:  Radiologe       Date:  2011-06       Impact factor: 0.635

7.  Concurrent use of endourological and radiologic methods in the management of high-grade renal trauma.

Authors:  Ardalan Akbari; Manraj K S Heran; Kourosh Afshar
Journal:  Can Urol Assoc J       Date:  2016-09-13       Impact factor: 1.862

8.  [The role of transarterial embolisation in the treatment of patients with abdominal injuries].

Authors:  A Platz; M Heinzelmann; N Helmy; O Trentz; T Pfammatter
Journal:  Chirurg       Date:  2004-08       Impact factor: 0.955

9.  Endovascular management of grade V blunt renal trauma with associated splenic injury.

Authors:  Arun Sahai; Faye Cuthbert; Ramon Niekrash; Midhat Siddiqui; Manpreet Singh Gulati
Journal:  Nat Rev Urol       Date:  2009-06       Impact factor: 14.432

10.  [Endovascular interventions for multiple trauma].

Authors:  C Kinstner; M Funovics
Journal:  Radiologe       Date:  2014-09       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.